Positive Feedback Between PU.1 and the Cell Cycle Controls Myeloid Differentiation by Kueh, Hao Yuan et al.
Positive feedback between PU.1 and the cell cycle controls
myeloid differentiation*
Hao Yuan Kueh1, Ameya Champhekhar1, Stephen L. Nutt2, Michael B. Elowitz1,3, and Ellen
V. Rothenberg1
1Division of Biology, California Institute of Technology, Pasadena, CA, USA
2The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia
3Howard Hughes Medical Institute, and Department of Bioengineering, California Institute of
Technology
Abstract
Regulatory gene circuits with positive feedback loops control stem cell differentiation, but several
mechanisms can contribute to positive feedback. Here, we dissect feedback mechanisms through
which the transcription factor PU.1 controls lymphoid and myeloid differentiation. Quantitative
live-cell imaging revealed that developing B-cells decrease PU.1 levels by reducing PU.1
transcription, whereas developing macrophages increase PU.1 levels by lengthening their cell
cycles, which causes stable PU.1 accumulation. Exogenous PU.1 expression in progenitors
increases endogenous PU.1 levels by inducing cell-cycle lengthening, implying positive feedback
between a regulatory factor and the cell cycle. Mathematical modeling showed that this cell-cycle
coupled feedback architecture effectively stabilizes a slow-dividing differentiated state. These
results show that cell cycle duration functions as an integral part of a positive auto-regulatory
circuit to control cell fate.
The transcription factor PU.1 is a central component of the regulatory gene network
controlling lymphoid and myeloid development from haematopoietic progenitors (1–4). It is
expressed at intermediate levels in progenitors, and its subsequent levels become a
determinant of lymphoid and myeloid fate choices, with down-regulation of PU.1 required
for B- and T- cell development and higher PU.1 levels favoring the development of
macrophages or myeloid dendritic cells (5–8).
Differential regulation of PU.1 during lymphoid and myeloid development involves
transcriptional positive feedback of PU.1 (9). PU.1 positively regulates its own transcription
in myeloid cells and stem cells, but not in lymphoid cells (10–13), and forms additional
positive feedback loops through mutual inhibition with other haematopoietic regulators (7,
14). Positive feedback can in principle generate multiple stable states with different levels of
regulatory factors, possibly accounting for the observed differences in PU.1 levels.
However, it is unclear how PU.1 is regulated during myeloid or lymphoid development,
what feedback mechanisms are involved, and why particular feedback architectures may
have been selected.
PU.1 promotes growth in several progenitor types (1, 15), but also coordinates cell-cycle
arrest with differentiation in myeloid progenitors. Reduced PU.1 activity causes acute
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myeloid leukemia, where progenitors fail to initiate differentiation growth arrest (16–19);
conversely, re-expression of PU.1 restores growth arrest (17, 20, 21). However, it is unclear
whether PU.1’s effect on the cell cycle influences its ability to regulate its own levels and
control differentiation.
Here, we analyzed PU.1 and cell cycle regulation in individual cells during early
macrophage and B-cell development (Fig. 1A). We isolated fetal liver progenitors (FLPs,
Lin-cKit+CD27+) from mice containing a bicistronic PU.1-GFP knock-in reporter (2),
cultured them with cytokines supporting B-cell and macrophage differentiation, and
analyzed PU.1-GFP levels over time by timelapse imaging or flow cytometry [Figs. 1, S1,
S2; (22)]. Importantly, PU.1-GFP levels varied linearly with nuclear PU.1 protein levels in
this culture system (Fig. S3). We found that progenitors initially expressed PU.1-GFP at
uniform levels, but subsequently up-regulated or down-regulated PU.1-GFP over time (Fig.
1B–D, Fig. S4). Cells up-regulating PU.1-GFP expressed the macrophage markers CD11b
and F4/80 but not the granulocyte marker Gr1, and were also large and adherent, reflecting
differentiation into macrophages (Fig. 1B, 1C–top right; Fig. S4). In contrast, cells down-
regulating PU.1-GFP expressed the B-cell marker CD19, and were also small and round,
reflecting differentiation into B-cells (Fig. 1B, 1C – bottom right; Figs. S2, S4). Developing
granulocytes and persisting progenitor-like cells maintained PU.1-GFP levels similar to
starting progenitors (Fig. 1B, Fig. S4). Both macrophages and B cells preferentially
developed from Fcγ receptor II/III (FcγR2/3)low FLPs, whereas FcγR2/3+ FLPs mostly
differentiated into granulocytes (Fig. S5, and see below). These results validate the use of
our system for analyzing PU.1 regulation during B-cell or macrophage differentiation.
Changes in PU.1 levels during B-cell or macrophage differentiation may result from changes
in either the rate of PU.1 synthesis or the rate of PU.1 removal (Fig. 1E), which would occur
predominantly through dilution due to cell division (23, 24), as PU.1’s protein half-life is
substantially longer than the progenitor cell-cycle length (Fig. S6). To determine how PU.1
levels were regulated, we measured PU.1 synthesis rates and cell cycle lengths for individual
cells within defined progenitor (Pro), macrophage (Mac) and B-cell (B) populations (Fig.
1D, Fig. S7). PU.1 synthesis rates could be measured by the slopes of stable PU.1-GFP
increase over time [(Δp/Δt for an observed cell cycle), Figs. 1E, S7; Fig. S8 shows GFP
stability], independent of average PU.1-GFP levels. Although cell movement precluded
comprehensive multigenerational tracking (Fig. S9), the movies allowed accurate
measurements of average cell cycle lengths and PU.1 synthesis rates for different cell
populations. Progenitors comprised two sub-populations with higher and lower rates of PU.1
synthesis (Fig. 1F, G). Switches between states with high and low PU.1 synthesis rates were
infrequent across cell division (Fig. 1G), suggesting that these states are maintained stably in
most cells. Macrophages had more PU.1-GFP and PU.1 protein than any of the progenitors,
as expected. Surprisingly, however, their PU.1 synthesis rates were not higher than that of
the progenitor sub-population with high PU.1 synthesis rates (Figs. 1F–H, S9). Instead, they
had significantly longer cell-cycle lengths (Figs. 1F–H, S9), and descended from ancestors
with shorter cell cycle lengths but similar PU.1 synthesis rates (Mac early, Fig. 1F–H). Thus,
developing macrophages increase their PU.1 levels by lengthening their cell cycles, which
allows PU.1 to accumulate to higher levels. In contrast, emerging B-cells had significantly
lower PU.1 synthesis rates than progenitors but similar cell cycle lengths (Fig. 1F–H, Fig.
S9). Thus, unlike macrophages, B cells decrease PU.1 levels by reducing PU.1 transcription.
Increased PU.1 levels caused by cell-cycle lengthening may be functionally important for
macrophage differentiation, or may simply reflect a consequence of differentiation growth
arrest (Fig. 2A). To distinguish between these two possibilities, we tested whether artificial
cell cycle lengthening promotes myeloid differentiation in a PU.1-dependent manner. We
induced cell-cycle lengthening in FLPs by two different methods–either by retroviral
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transduction of cyclin-dependent kinase (CDK)-inhibitors p21Cip1 (Cdkn1a) or p27Kip1
(Cdkn1b) (Fig. 2B, Fig. S10), or by treatment with PD0332991, a CDK4/6 inhibitor (25)
(Fig. 2C, D). Induced cell-cycle lengthening in progenitors increased PU.1-GFP and PU.1
levels, and increased the percentage of myeloid cells, with these increases being most
dramatic in the slowest-dividing cells (Fig 2B, C). This differentiation depended on PU.1
activity, because in cells transduced with a competitive inhibitor of PU.1 (PU.1-ets, Fig.
S11), PD0332991 treatment still increased PU.1-GFP, but no longer increased the fraction of
CD11b-expressing cells as in empty vector (EV)-transduced cells (Fig. 2C, D). These results
suggest that PU.1 accumulation as a result of cell-cycle lengthening is functionally
important for macrophage differentiation.
To examine how positive transcriptional feedback regulates PU.1’s own expression (10–13),
we tested how PU.1 and dominant negative PU.1 transduction affected transcription of the
PU.1-GFP reporter. Forced expression of PU.1-ets in FLPs reduced PU.1-GFP levels (Fig.
S12), implying that a threshold level of PU.1 activity is important for maximal PU.1
expression. Conversely, flow cytometry and imaging showed that exogenous PU.1 up-
regulated PU.1-GFP and CD11b, while inhibiting PU.1-GFP down-regulation and CD19 up-
regulation (Fig. 3A–B, Fig. S13). However, imaging analysis (cf. Fig. 1E) showed that
exogenous PU.1 expression did not increase endogenous PU.1 synthesis rates; instead, it
induced cell cycle lengthening in a sub-population of progenitors, which in turn led to the
significant increase in PU.1-GFP levels (Fig. 3C–D, Fig. S14). This cell-cycle lengthening
occurred preferentially in FcγR2/3low FLPs (Fig. S5C), which accounted for most of the
macrophage potential in the FLP population. Thus, high PU.1 levels promote cell-cycle
lengthening in cells capable of generating macrophages, which in turn allows high PU.1
levels to be stably maintained. Taken together, our results provide evidence for a regulatory
circuit architecture involving positive feedback on a transcription factor through the cell
cycle.
Insight into cell-cycle lengthening mechanisms emerged from analysis of regulatory gene
expression in PU.1-transduced progenitors (Fig. 3E). Consistent with PU.1 auto-regulation
through cell-cycle lengthening rather than transcriptional acceleration, PU.1 transduction did
not affect endogenous PU.1 mRNA levels, but significantly reduced the levels of cell-cycle
promoting factors Cyclin D2 (Ccnd2) and Cdc25a. Consistent with other studies (26–28),
exogenous PU.1 also reduced the levels of Myb and Myc, growth-promoting proto-
oncogenes that are down-regulated during normal differentiation. Exogenous PU.1 also
reduced levels of p21 and Gfi1, which can mediate quiescence, although these are up-
regulated by PU.1 in stem cells (13). Thus, the mechanisms underlying PU.1-mediated cell
cycle arrest during macrophage differentiation appear distinct from those operating in stem
cell quiescence.
How can positive feedback between PU.1 and the cell cycle stabilize a slow-dividing
macrophage state with high PU.1 levels? To address this issue, we constructed a stochastic
single-cell dynamical model, where PU.1 inhibits the G1 to S cell cycle transition above a
threshold concentration (Fig. 4A, top). This model exhibits bi-stability, supporting both a
fast-dividing low-PU.1 state and a slow-dividing high-PU.1 state (Fig. 4A; Figs. S15-S16).
In our simple model, G1 checkpoint release depends solely on PU.1 levels; during
macrophage development, other regulatory factors also promote checkpoint release and thus
regulate feedback engagement. Once the high PU.1 state is established, it is relatively stable
compared to the corresponding state of a hypothetical pure transcriptional feedback system
with similar parameters, which exhibits more frequent spontaneous switches between states
due to larger, more rapid protein fluctuations [Fig. S17, see (22)]. Taken together, these
results show how cell-cycle coupled feedback provides a simple mechanism to support
multiple stable states that exhibit different rates of cell division.
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Besides cell-cycle coupled feedback, cells also contain PU.1 transcriptional feedback, which
appears to take effect at lower PU.1 levels (Fig. S12). When both feedbacks are incorporated
simultaneously, the model can generate three stable steady states with low, medium and high
levels of PU.1 corresponding to the pro-B, progenitor and macrophage populations
respectively (Fig. 4B–C). Because of its lower PU.1 threshold, transcriptional feedback
allows developing B-cells to down-regulate PU.1 while maintaining similar rates of division,
consistent with observations. We propose this dual feedback system as a working model for
further study of PU.1 regulation during lymphoid and myeloid development.
Could cell-cycle coupled feedback operate in other systems? Interestingly, a similar type of
bi-stability was recently observed in a bacterial synthetic cell-cycle coupled feedback circuit
(29). In the context of cell differentiation, other fate regulators have also been shown to
promote cell-cycle arrest (30). Although some transcription factors are notoriously short-
lived (e.g. Fos), recent studies have found that many mammalian proteins are stable over
multiple cell cycles (23, 24), and other regulatory proteins may resemble PU.1 in this
respect. Moreover, induced cell-cycle lengthening is known to promote differentiation in
other systems (31, 32), suggesting that mechanisms based on accumulation of stable fate
regulators during cell-cycle arrest may be more prevalent. Where cell fate decisions depend
on the balance between two factors with different stabilities – such as PU.1 and the unstable
C/EBPα, for instance (33, 34) – cell cycle speed may act as a tiebreaker, with slowing
favoring the more stable factor and acceleration favoring the less stable one. In general, our
results imply a mutual regulatory relationship between the cell cycle and transcription factor
activities in cell differentiation, and similar relationships may impact other processes that
involve cell cycle length changes, such as cancer.
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Fig. 1. Cell-cycle lengthening drives PU.1 up-regulation during macrophage development
FLPs (Lin-cKit+CD27+) from E13.5 PU.1-GFP mice were cultured with B- and
macrophage-supporting cytokines (SCF, IL-3, IL-7, Flt3L, M-CSF) and analyzed using
timelapse imaging or flow cytometry. A) Schematic showing myeloid and lymphoid
development from haematopoietic progenitor cells. B) Histograms (left) (left) show PU.1-
GFP levels measured after the indicated number of days in culture. Dotted lines give initial
PU.1-GFP levels. Flow cytometry plots (right) show CD19, CD11b and Gr-1 levels against
PU.1-GFP after six days. C) Merged DIC (gray) and PU.1-GFP fluorescence (green) images
of cultured FLPs, taken after the indicated number of hours. Cells with PU.1-GFP time
traces shown in F) are marked with correspondingly colored arrowheads. Scale bar = 20 μm.
D) Heat map showing PU.1-GFP levels over time for all imaged cells. Rectangles define
progenitor (gray), macrophage (blue) and B-cell (red) populations. E) Alternative
hypotheses for PU.1-GFP up-regulation in macrophages. The PU.1 synthesis rate for a
single cell is given by (Δp/Δt) over the entire observed cell cycle. F) Representative single-
cell PU.1-GFP time traces for different cell populations. Data are taken from lineages shown
in Fig. S9. Horizontal lines give PU.1-GFP level thresholds for the defined cell populations.
G) Histogram (top) showing distribution of PU.1 synthesis rates in progenitors. Scatterplot
shows relationship between PU.1 synthesis rates in mother versus daughter cells. Horizontal
and vertical lines indicate the threshold for progenitor sub-populations with higher and
lower rates of PU.1 synthesis. H) Plots comparing mean PU.1-GFP levels (top), PU.1
synthesis rates (middle) and cell cycle lengths (bottom) in different cell populations. Red
crosses indicate boxplot outliers. Bottom error bars represent 95% confidence intervals.
Asterisks indicate significantly different means (p<10−7, one-tailed t-test). Data are
representative of three independent experiments.
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Figure 2. PU.1 accumulation due to cell-cycle lengthening is important for myeloid
differentiation
A) Two hypotheses for the function of high PU.1 levels in differentiating macrophages. B)
FLPs were transduced with empty vector (EV), p21, or p27, cultured for four days and
analyzed by flow cytometry. Histograms (top) show CellTrace Violet and PU.1-GFP levels
for different transduced populations. Gray shaded area indicates slow-dividing cell gate.
Flow plots (bottom) show CD11b versus PU.1-GFP levels for different transduced cell
populations. C) FLPs transduced with EV or PU.1 antagonist (PU.1-ets) were cultured for 3
days with or without 2.1 μM CDK4/6 inhibitor PD0332991, and analyzed by flow
cytometry. Flow plots show CellTrace Violet (top) or CD11b (bottom) versus PU.1-GFP for
the different conditions. D) Effects of PD0332991 and PU.1-ets transduction on the
percentage of myeloid cells. Bars represent means of two independent experiments, and
circles give individual measurements.
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Fig. 3. PU.1 up-regulates its own expression during macrophage development by inducing cell-
cycle lengthening
FLPs transduced with EV or PU.1 retroviral constructs were sorted and cultured with multi-
lineage supporting cytokines (SCF, IL-3, IL-7, Flt3L). A) Histogram showing PU.1-GFP
levels (top), and flow plots showing CD11b versus PU.1-GFP levels after four days of
culture (bottom). B) Heat maps comparing time evolution of PU.1-GFP levels for imaged
EV- or PU.1-transduced cells. C) Representative PU.1-GFP time traces for EV or PU.1-
transduced cells, taken from lineage trees shown in Fig. S14. D) Box-plots comparing EV-
and PU.1-transduced progenitors, showing percentage of slow dividing cells (top), along
with maximal PU.1-GFP levels (middle), and PU.1 synthesis rate (bottom) for both the
entire PU.1-transduced progenitor population and slow-dividing progenitors alone. Red
crosses indicate outliers. Asterisks indicate significantly different means (% slow dividing, p
< 0.05, χ2 test, d.f. = 1; maximal PU.1-GFP, one-tailed t-test, p<0.005). Data are
representative of two independent experiments. E) EV or PU.1-transduced FcγR2/3low FLPs
were cultured for 2 days, harvested for RNA and analyzed using qRT-PCR. Bar chart shows
mRNA level fold change for the indicated genes in PU.1-transduced as compared to EV-
transduced cells. Bars represent the means of two independent experiments, and circles
represent individual measurements (*-p < 0.1; **-p < 0.01; two-tailed t-test).
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Fig. 4. A cell-cycle coupled feedback loop stably maintains a slow-dividing differentiated state
A) Schematic of a cell-cycle coupled positive feedback loop (top), and time traces from
stochastic simulations of this circuit architecture (bottom), showing four cells with different
initial PU.1 levels but identical rate constants. B) Schematic of a hybrid cell-cycle coupled/
transcriptional positive feedback circuit (top), and stochastic simulations of this architecture
(bottom), showing maintenance of three stable steady-states. C) Phase diagrams for the two
circuit architectures, showing PU.1 synthesis rates (black – hybrid; gray – cell-cycle
coupled), as well as dilution rate and cell division rate (same for both models) against PU.1
levels. Red, gray and blue circles denote B, progenitor and macrophage steady-states
respectively, and arrows indicate flow of the system. A thorough analysis and discussion of
all models is given in the mathematical appendix (22).
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